Compare Liquidia Corporation Common Stock (LQDA) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Microchip Technology Inc. — how do they compare? Liquidia Corporation Common Stock trades at $34.27 (market cap $3.04B), while Microchip Technology Inc. trades at $70.39 (market cap $38.69B). The key difference: Microchip Technology Inc. is far larger — about 12.7× Liquidia Corporation Common Stock's market cap, and Microchip Technology Inc. pays a 2.55% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Microchip Technology Inc. for 63 Days on average.
| LQDA | MCHP | |
|---|---|---|
Market Cap | $3.04B | $38.69B |
Volume | 21,111,778 | 14,380,005 |
Sector | Health | Technology |
52-Week High | $91.03 | $102.97 |
52-Week Low | $22.02 | $49.02 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $2.94B | $43.82B |
Dividend Yield | — | 2.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Microchip Technology (MCHP) trades at $74.16, up 0.45% on the day, with a bearish technical signal but strong analyst consensus. The company has beaten EPS estimates for the last three quarters, though 2025 saw a net loss amid revenue contraction. Recent news highlights expansion in Ethernet and 48V power portfolios, along with the completed acquisition of Hailo, targeting growth in automotive, industrial, and AI infrastructure markets.
The outlook is mixed: robust buy-side analyst support and strategic positioning in high-growth sectors offer upside potential, but high valuation multiples, significant debt, and recent profitability challenges present risks. The consensus price target of $110.50 implies substantial appreciation, contingent on successful execution and market demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
